Abstract:In patients with systemic sclerosis (SSc), interstitial lung disease (ILD) is a factor in the decline of functional capacity up to disability and is also the leading cause of death. Therefore, one of the most important tasks in the treatment of this group of patients is not only to detect involvement of respiratory system, but also to predict the likelihood of its development. Objective : to study the possibility of predicting the development of ILD and advanced ILD in patients with SSc. Material and methods . The study included 79 patients with SSc (mean age 64.4±11.5 years; 94.9% women) from the Registry of myositis, SSc and Mixed Connective Tissue Diseases (РЕМИССиС) who underwent high-resolution computed tomography (HRCT) of the lungs. Classification trees (CTr) were constructed to predict the development of widespread ILD using the CHAID algorithm (exhaustive). All patients were tested for antibodies against Scl-70 (anti-Scl-70), CENP-B (anti-CENP-B), and PmScl (anti-PmScl). Results and discussion . ILD signs according to HRCT were detected in 53 patients. Fibrotic (34.2%) and cellular (15.2%) types of nonspecific interstitial pneumonia were the most common, and common interstitial pneumonia was less frequent (11.4%).The presence of ILD and advanced ILD (involvement of more than 20% of the lung parenchyma) were significantly associated with the detection of any autoantibodies, except anti-centromere antibodies, an increase in pulmonary artery systolic pressure, a decrease in forced vital capacity, diffusing capacity of the lungs, blood oxygen saturation at rest, and all parameters of six-minute walk test (6MWT), and complaints of shortness of breath. In addition, the presence of extensive ILD was also significantly associated with diffuse SSc and with SSc without skin manifestations. In establishing the CTr, it was found that the development of widespread ILD was unlikely in individuals who were able to walk more than 440 m in 6MWT and had neither anti-Scl-70 nor anti-PmScl. Significant associations were also found between the radiological pattern of ILD and the types of disease-specific antibodies. Conclusion . The 6MWT data in conjunction with the results of testing for SSc-specific autoantibodies provide a very accurate prediction of the presence and extent of ILD. It is advisable to include these indicators in the algorithm for screening and monitoring patients with SSc.

Characterisation of incident interstitial lung disease in late systemic sclerosis

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis

Predictors of progression in systemic sclerosis patients with interstitial lung disease

Interstitial Lung Disease Associated with Systemic Sclerosis

Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort

Pathogenesis of interstitial lung disease in systemic sclerosis

Ways to predict interstitial lung disease in patients with systemic sclerosis: results of an observational study

Progressive pulmonary fibrosis and its impact on survival in systemic sclerosis-related interstitial lung disease

Predictive factors for interstitial lung disease progression in a Singapore systemic sclerosis cohort: a multicentre study

Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis

Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience

Long-term functional course of Sjögren's disease-associated interstitial lung disease

Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review

Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database

Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis

Chronic interstitial lung disease associated with systemic lupus erythematosus: A multicentric study of 89 cases

Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France

Patterns of Interstitial Lung Disease in Egyptian Patients with Systemic Sclerosis: Relation to Disease Parameters

Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis

Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis